Josep Maria Corominas
Overview
Explore the profile of Josep Maria Corominas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vernet-Tomas M, Mena M, Alemany L, Bravo I, de Sanjose S, Nicolau P, et al.
Anticancer Res
. 2015 Feb;
35(2):851-6.
PMID: 25667466
Background/aim: Great controversy exists about the association between Human Papillomavirus (HPV) and breast tumors. The aim of this study was to explore the presence of HPV DNA in a large...
2.
Castells X, Domingo L, Corominas J, Tora-Rocamora I, Quintana M, Bare M, et al.
Breast Cancer Res Treat
. 2014 Dec;
149(1):237-44.
PMID: 25503778
Benign breast disease increases the risk of breast cancer. This association has scarcely been evaluated in the context of breast cancer screening programs although it is a prevalent finding in...
3.
Bosch A, Panoutsopoulou K, Corominas J, Gimeno R, Moreno-Bueno G, Martin-Caballero J, et al.
Oncotarget
. 2014 Apr;
5(8):2065-76.
PMID: 24742605
In early stages of metastasis malignant cells must acquire phenotypic changes to enhance their migratory behavior and their ability to breach the matrix surrounding tumors and blood vessel walls. Epigenetic...
4.
Rojo F, Domingo L, Sala M, Zazo S, Chamizo C, Menendez S, et al.
Cancer Epidemiol Biomarkers Prev
. 2013 Dec;
23(2):288-99.
PMID: 24347552
Background: The development and progression of true interval breast cancers (tumors that truly appear after a negative screening mammogram) is known to be different from screen-detected cancers. However, the worse...
5.
Dalmases A, Gonzalez I, Menendez S, Arpi O, Corominas J, Servitja S, et al.
Oncotarget
. 2013 Dec;
5(1):196-210.
PMID: 24344116
NF-кB has been linked to doxorubicin resistance in breast cancer patients. NF-кB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively examined; however its functional relevance...
6.
Domingo L, Blanch J, Servitja S, Corominas J, Murta-Nascimento C, Rueda A, et al.
Eur J Cancer Prev
. 2012 May;
22(1):21-8.
PMID: 22584215
The question of whether screen detection confers an additional survival benefit in breast cancer is unclear and subject to several biases. Our aim was to examine the role of the...
7.
Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodriguez M, Garcia-Puche J, et al.
Breast Cancer Res
. 2012 May;
14(3):R71.
PMID: 22554015
Introduction: Increasing evidence supports the view that the detection of circulating tumor cells (CTCs) predicts outcomes of nonmetastatic breast cancer patients. CTCs differ genetically from the primary tumor and may...
8.
Jones R, Rojo F, AHern R, Villena N, Salter J, Corominas J, et al.
J Clin Pathol
. 2010 Dec;
64(2):130-5.
PMID: 21148141
Aims: To evaluate the clinicopathological associations and predictive value of the transcription factor NF-κB in a large series of breast cancer patients treated with neoadjuvant chemotherapy. Methods: A retrospective search...
9.
Rojo F, Gracias E, Villena N, Cruz T, Corominas J, Corradino I, et al.
Clin Cancer Res
. 2010 Apr;
16(8):2474-82.
PMID: 20371675
Purpose: To assess the pharmacodynamic effects of nimotuzumab, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody with intermediate affinity for the receptor, in skin and tumor tissues from head and...
10.
Domingo L, Sala M, Servitja S, Corominas J, Ferrer F, Martinez J, et al.
Cancer Causes Control
. 2010 Mar;
21(8):1155-64.
PMID: 20349271
Objective: To analyze phenotypic classification and other risk factors for interval breast cancer, focusing on true interval and false negative cancers. Methods: A nested case-control study was performed among 115...